DE602004017283D1 - Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür - Google Patents

Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür

Info

Publication number
DE602004017283D1
DE602004017283D1 DE602004017283T DE602004017283T DE602004017283D1 DE 602004017283 D1 DE602004017283 D1 DE 602004017283D1 DE 602004017283 T DE602004017283 T DE 602004017283T DE 602004017283 T DE602004017283 T DE 602004017283T DE 602004017283 D1 DE602004017283 D1 DE 602004017283D1
Authority
DE
Germany
Prior art keywords
heart failure
treating heavy
medicament therefor
heavy heart
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004017283T
Other languages
German (de)
English (en)
Inventor
Atsushi Ozaki
Yosuke Maki
Osamu Sato
Yoshitaka Yamamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32908667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004017283(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE602004017283D1 publication Critical patent/DE602004017283D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004017283T 2003-02-24 2004-02-23 Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür Expired - Lifetime DE602004017283D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44887803P 2003-02-24 2003-02-24
PCT/JP2004/002085 WO2004073716A1 (en) 2003-02-24 2004-02-23 Method for treating severe heart failure and medicament therefor

Publications (1)

Publication Number Publication Date
DE602004017283D1 true DE602004017283D1 (de) 2008-12-04

Family

ID=32908667

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004017283T Expired - Lifetime DE602004017283D1 (de) 2003-02-24 2004-02-23 Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür

Country Status (23)

Country Link
US (2) US7423032B2 (enExample)
EP (2) EP1596868B1 (enExample)
JP (2) JP4771937B2 (enExample)
KR (1) KR100706727B1 (enExample)
CN (1) CN100577171C (enExample)
AR (1) AR043259A1 (enExample)
AT (1) ATE411803T1 (enExample)
AU (2) AU2004212842B9 (enExample)
BR (1) BRPI0405657A (enExample)
CA (1) CA2493475A1 (enExample)
CY (1) CY1108583T1 (enExample)
DE (1) DE602004017283D1 (enExample)
DK (1) DK1596868T3 (enExample)
ES (1) ES2315640T3 (enExample)
MX (1) MXPA05001623A (enExample)
MY (1) MY143740A (enExample)
NO (1) NO335369B1 (enExample)
PL (2) PL218069B1 (enExample)
PT (1) PT1596868E (enExample)
RU (2) RU2346689C2 (enExample)
SI (1) SI1596868T1 (enExample)
TW (1) TWI322689B (enExample)
WO (1) WO2004073716A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7468390B2 (en) * 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
PT1968990E (pt) 2005-12-27 2015-03-16 Otsuka Pharma Co Ltd Composto de benzoazepina solúvel em água e a sua composição farmacêutica
JP5076327B2 (ja) * 2006-02-01 2012-11-21 味の素株式会社 分岐鎖アミノ酸の心不全適応
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
AU2008254273B2 (en) * 2007-05-15 2013-03-28 Otsuka Pharmaceutical Co., Ltd. Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
ES2903231T3 (es) 2008-02-26 2022-03-31 Jenavalve Tech Inc Stent para el posicionamiento y anclaje de una prótesis valvular en un sitio de implantación en el corazón de un paciente
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
JP2013526388A (ja) 2010-05-25 2013-06-24 イエナバルブ テクノロジー インク 人工心臓弁、及び人工心臓弁とステントを備える経カテーテル搬送体内プロテーゼ
JP5477413B2 (ja) * 2012-04-24 2014-04-23 味の素株式会社 分岐鎖アミノ酸の心不全適応
WO2015028209A1 (en) 2013-08-30 2015-03-05 Jenavalve Technology Gmbh Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US12121461B2 (en) 2015-03-20 2024-10-22 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath
WO2016177562A1 (en) 2015-05-01 2016-11-10 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
CN110174474B (zh) * 2019-05-24 2022-02-18 石家庄四药有限公司 复方电解质注射液(ⅱ)中l-苹果酸异构体的检测方法
CN112121051B (zh) * 2020-09-30 2021-06-18 郑州大学 莫扎伐坦在制备抗消化道肿瘤药物中的应用
CN120152682A (zh) 2022-11-09 2025-06-13 耶拿阀门科技公司 用于顺序地部署可扩张植入物的导管系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01102124A (ja) 1987-10-14 1989-04-19 Kubota Ltd コンクリート構造体支持構造
DE69026708T2 (de) 1989-10-20 1997-04-03 Otsuka Pharma Co Ltd Benzoheterozyklische verbindungen
US5753677A (en) 1989-10-20 1998-05-19 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5258510A (en) 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
TW249201B (enExample) 1992-07-02 1995-06-11 Otsuka Pharma Co Ltd
JPH0680641A (ja) 1992-09-01 1994-03-22 Otsuka Pharmaceut Co Ltd 光学活性な５−ヒドロキシベンゾアゼピン誘導体の製造法
TW354762B (en) 1993-02-23 1999-03-21 Otsuka Pharma Co Ltd Agent for prophylaxis or treatment of cataract
JP2694319B2 (ja) 1993-12-24 1997-12-24 大塚製薬株式会社 抗潰瘍剤
JP3002766B2 (ja) * 1994-12-09 2000-01-24 大塚製薬株式会社 脳浮腫治療剤
JPH10120592A (ja) 1996-10-22 1998-05-12 Otsuka Pharmaceut Co Ltd メニエール病乃至メニエール症候群治療剤
JP4210355B2 (ja) * 1997-07-03 2009-01-14 大塚製薬株式会社 固形製剤組成物
US20030103983A1 (en) * 2002-05-09 2003-06-05 Pressler Milton Lethan Ace inhibitor-vasopressin antagonist combinations
ATE341342T1 (de) 2000-01-26 2006-10-15 Astellas Pharma Inc Ace inhibitor-vasopressin antagonist kombinationen
US20030008860A1 (en) 2002-05-09 2003-01-09 Bakker-Arkema Rebecca Guggemos Treatment of congestive heart failure
CA2357833C (en) 2000-10-04 2005-11-15 Warner-Lambert Company Treatment of pulmonary hypertension using vasopressin antagonist
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor

Also Published As

Publication number Publication date
PL373432A1 (en) 2005-08-22
KR100706727B1 (ko) 2007-04-12
EP1596868B1 (en) 2008-10-22
DK1596868T3 (da) 2008-12-08
KR20050105972A (ko) 2005-11-08
RU2005102110A (ru) 2005-09-20
BRPI0405657A (pt) 2005-07-19
ATE411803T1 (de) 2008-11-15
CY1108583T1 (el) 2014-04-09
NO20050569D0 (no) 2005-02-02
US20050187210A1 (en) 2005-08-25
EP1596868A1 (en) 2005-11-23
SI1596868T1 (sl) 2008-12-31
AU2004212842A1 (en) 2004-09-02
JP2006518731A (ja) 2006-08-17
AU2009201109A1 (en) 2009-04-09
MY143740A (en) 2011-07-15
CN100577171C (zh) 2010-01-06
ES2315640T3 (es) 2009-04-01
CA2493475A1 (en) 2004-09-02
TWI322689B (en) 2010-04-01
PL218069B1 (pl) 2014-10-31
PT1596868E (pt) 2009-01-14
US7423032B2 (en) 2008-09-09
EP2000142A1 (en) 2008-12-10
RU2008133654A (ru) 2010-02-20
JP4771937B2 (ja) 2011-09-14
CN1700919A (zh) 2005-11-23
JP2011148806A (ja) 2011-08-04
AU2004212842B9 (en) 2009-03-05
NO335369B1 (no) 2014-12-01
RU2346689C2 (ru) 2009-02-20
AR043259A1 (es) 2005-07-20
AU2004212842B2 (en) 2009-01-08
WO2004073716A1 (en) 2004-09-02
EP1596868A4 (en) 2006-03-29
TW200418489A (en) 2004-10-01
MXPA05001623A (es) 2005-04-25
US20080214523A1 (en) 2008-09-04
PL404315A1 (pl) 2013-08-05
US7749993B2 (en) 2010-07-06
NO20050569L (no) 2005-11-22
HK1084037A1 (zh) 2006-07-21

Similar Documents

Publication Publication Date Title
DE602004017283D1 (de) Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür
EP1701664A4 (en) SYSTEM AND METHOD FOR PROCESSING A FABRIC
EP1626730A4 (en) METHOD, DEVICE AND COMPOSITION FOR TREATING ACNE
ATE489955T1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
EP1482962A4 (en) METHOD OF TREATING THIOREDOXIN-MEDIATED DISEASES (TRX)
EP1896083A4 (en) METHOD FOR TREATING PUMP DISEASE USING 1-DEOXYNOJIRIMYCIN AND ITS DERIVATIVES
EP1651164A4 (en) COMPOSITION AND METHOD FOR TREATING NEUROLOGICAL DISORDERS
DE602006019753D1 (de) Verfahren und gerät zur behandlung von aneurysmen der a. thoracica
DE602004021790D1 (de) Verfahren zur behandlung von parkinson-krankheit
DE602004023829D1 (de) Verfahren zur behandlung von sinuskopfschmerzen
EP1565230A4 (en) COMPOSITIONS OF MATERIALS AND ASSOCIATED SYSTEMS AND METHODS FOR THE TREATMENT OF CARDIAC CONDITIONS
DE60334517D1 (de) System und Verfahren zur Durchführung von am-Chip Selbsttests
DE602004017658D1 (de) Zur Behandlung von Schmerzen geeignete therapeutische Mittel
EP1916964A4 (en) IMPLANTS AND METHODS FOR THE REPAIR, REPLACEMENT AND TREATMENT OF JOINT DISEASES
EP1635801A4 (en) METHODS OF TREATMENT AND PREVENTION OF CARDIAC ARRHYTHMIA
DE602004022036D1 (de) Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen
ATE474602T1 (de) Verfahren zur behandlung von hiv-infektion
EP1550462A4 (en) REMEDY OR PREVENTIVE AGENT AGAINST KIDNEY DISEASE AND METHOD OF DIAGNOSING KIDNEY DISEASE
DE602004016712D1 (de) Vorrichtung und Verfahren zur Bestimmung von Blutkomponenten
DE602004001134D1 (de) Tetrazolderivate und verfahren zur behandlung von stoffwechselbedingten erkrankungen damit
EP1651237A4 (en) METHODS OF TREATING DERMATOLOGICAL DISORDERS
EP1684735A4 (en) COMPOUNDS AND METHODS FOR TREATMENT AND PREVENTION OF CARDIAC ARRHYTHMIES INDUCED BY PHYSICAL EXERCISE
DE602004026405D1 (de) Formulierung und verfahren zur behandlung von thrombocythämie
DE60327856D1 (de) Zusammensetzungen und verfahren zur hautbräunung
DE602004010548D1 (de) Verfahren zur behandlung von tierhäuten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition